Is MXDHF or DIVO a better dividend investment in 2026?

MXDHF currently yields 800.00% with a 5% 5-year dividend growth rate. DIVO yields 6.49% with 5% growth. The better choice depends on your goal: MXDHF offers higher current income.

What is the dividend yield difference between MXDHF and DIVO?

MXDHF has a forward dividend yield of 800.00% ($2.00/share annually). DIVO yields 6.49% ($2.91/share annually). The yield gap is 793.51 percentage points.

Home › Compare › MXDHF vs DIVO

MXDHF vs DIVO: Dividend Comparison 2026

MXDHF yields 800.00% · DIVO yields 6.49%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 MXDHF wins by $2773896.43M in total portfolio value

INVESTMENT

TIME HORIZON10 years

MXDHF

● Live price

800.00%

Share price

$0.25

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$2773896.46M

Annual income

$2,226,430,694,490.38

Full MXDHF calculator →

DIVO

● Live price

6.49%

Share price

$44.85

Annual div

$2.91

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$30.7K

Annual income

$981.68

Full DIVO calculator →

Portfolio growth — MXDHF vs DIVO

📍 MXDHF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	MXDHF	DIVO
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, MXDHF + DIVO cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

MXDHF pays

DIVO pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

MXDHF

Annual income on $10K today (after 15% tax)

$68,000.00/yr

After 10yr DRIP, annual income (after tax)

$1,892,466,090,316.82/yr

DIVO

Annual income on $10K today (after 15% tax)

$552.00/yr

After 10yr DRIP, annual income (after tax)

$834.43/yr

At 15% tax rate, MXDHF beats the other by $1,892,466,089,482.39/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of MXDHF + DIVO for your $10,000?

MXDHF: 50%DIVO: 50%

100% DIVO50/50100% MXDHF

Portfolio after 10yr

$1386948.25M

Annual income

$1,113,215,347,736.03/yr

Blended yield

80.26%

📊

Analyst Conviction Gap

Where Wall Street is most bullish on MXDHF right now

MXDHF

Analyst Ratings

Buy

Consensus: Buy

Altman Z

-3.4

Piotroski

4/9

DIVO

No analyst data

Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

MXDHF buys

DIVO buys

No recent congressional trades found for MXDHF or DIVO in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricMXDHFDIVO

Forward yield	800.00% ✓	6.49%
Annual dividend / share	$2.00	$2.91 ✓
Payout ratio	50%	50%
1-year div growth	0%	0%
5-year div CAGR	0%	0%
Portfolio after 10y	$2773896.46M ✓	$30.7K
Annual income after 10y	$2,226,430,694,490.38 ✓	$981.68
Total dividends collected	$2730603.49M ✓	$8.2K
Payment frequency	quarterly	quarterly
Sector	Stock	ETF

Year-by-year: MXDHF vs DIVO ($10,000, DRIP)

Year	MXDHF Portfolio	MXDHF Income/yr	DIVO Portfolio	DIVO Income/yr	Gap
1← crossover	$90,700	$80,000.00	$11,349	$649.42	+$79.4K → MXDHF
2	$775,180	$678,130.84	$12,833	$688.83	+$762.3K → MXDHF
3	$6,246,019	$5,416,576.76	$14,459	$727.90	+$6.23M → MXDHF
4	$47,472,138	$40,788,897.61	$16,238	$766.49	+$47.46M → MXDHF
5	$340,525,323	$289,730,135.14	$18,179	$804.47	+$340.51M → MXDHF
6	$2,306,680,888	$1,942,318,792.24	$20,293	$841.71	+$2306.66M → MXDHF
7	$14,764,459,529	$12,296,310,979.28	$22,591	$878.14	+$14764.44M → MXDHF
8	$89,354,478,583	$73,556,506,887.09	$25,087	$913.65	+$89354.45M → MXDHF
9	$511,650,252,638	$416,040,960,553.41	$27,791	$948.18	+$511650.22M → MXDHF
10	$2,773,896,464,813	$2,226,430,694,490.38	$30,718	$981.68	+$2773896.43M → MXDHF

MXDHF vs DIVO: Complete Analysis 2026

MXDHF — Stock

MDxHealth SA, a commercial-stage precision diagnostics company, provides urologic solutions in the United States, the Netherlands, Belgium, Spain, Poland, Italy, rest of European Union, and internationally. Its novel prostate cancer genomic testing solutions are SelectMDx, a non-invasive urine test; and ConfirmMDx, an epigenetic test, which provide physicians with a clinical pathway to identify clinically prostate cancer while minimizing the use of invasive procedures that are prone to complications. The company was formerly known as OncoMethylome Sciences SA and changed its name to MDxHealth SA in October 2010. MDxHealth SA was incorporated in 2003 and is headquartered in Herstal, Belgium.

Full MXDHF Calculator →

DIVO — ETF

DIVO is an ETF of high-quality large cap companies with a history of dividend and earnings growth, along with a tactical covered call* strategy on individual stocks. DIVO is strategically designed to offer high levels of total return on a risk-adjusted basis.

Full DIVO Calculator →

📬

Get this MXDHF vs DIVO comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

MXDHF vs SCHD MXDHF vs JEPI MXDHF vs O MXDHF vs KO MXDHF vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.